These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2563628)

  • 1. Beneficial effects of glucose polymer and an H2-receptor blocker in a patient with a proximal ileostomy.
    Saunders DR; Saunders MD; Sillery JK
    Am J Gastroenterol; 1989 Feb; 84(2):192-4. PubMed ID: 2563628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ox bile treatment of severe steatorrhea in an ileectomy-ileostomy patient.
    Fordtran JS; Bunch F; Davis GR
    Gastroenterology; 1982 Mar; 82(3):564-8. PubMed ID: 7054048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteral glucose-polymer-electrolyte solution in the treatment of chronic fluid and electrolyte depletion in short-bowel syndrome.
    Laustsen J; Fallingborg J
    Acta Chir Scand; 1983; 149(8):787-8. PubMed ID: 6421037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenckhoff catheter administration of intraperitoneal fluid and electrolytes for long-term management of intractable ileostomy diarrhea: a case report.
    August DA; Sugarbaker PH
    Surgery; 1985 Feb; 97(2):237-41. PubMed ID: 3969628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short bowel syndrome following resection for Crohn's disease.
    Kristensen M; Lenz K; Nielsen OV; Jarnum S
    Scand J Gastroenterol; 1974; 9(6):559-65. PubMed ID: 4424368
    [No Abstract]   [Full Text] [Related]  

  • 6. High-output stoma after small-bowel resections for Crohn's disease.
    Tsao SK; Baker M; Nightingale JM
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):604-8; quiz 609. PubMed ID: 16327840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective use of total parenteral nutrition in an ileostomy patient.
    Iles M
    J Am Diet Assoc; 1984 Nov; 84(11):1324-8. PubMed ID: 6436357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine: clinical applications of a new H2-receptor antagonist. Introduction.
    Texter EC
    Am J Med; 1986 Oct; 81(4B):1-2. PubMed ID: 2877567
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of a satellite symposium on famotidine: further developments in H2-receptor antagonist therapy. World Congresses of Gastroenterology meeting. São Paulo, Brazil, 12 September 1986.
    Scand J Gastroenterol Suppl; 1987; 134():1-62. PubMed ID: 2889254
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
    [No Abstract]   [Full Text] [Related]  

  • 12. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract]   [Full Text] [Related]  

  • 13. Famotidine: an evolution in H2 antagonist therapy. Proceedings of a symposium. São Paulo, Brazil, September 7-12, 1986.
    J Clin Gastroenterol; 1987; 9 Suppl 2():1-27. PubMed ID: 2887612
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of developments in H2-receptor antagonist therapy: focus on famotidine. Proceedings of an official satellite symposium to the 8th Asian-Pacific Congress on Gastroenterology and the 5th Asian-Pacific Congress of Digestive Endoscopy. Seoul, Korea, 10 October 1988.
    J Int Med Res; 1989; 17 Suppl 1():1A-53A. PubMed ID: 2566538
    [No Abstract]   [Full Text] [Related]  

  • 15. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
    Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL
    J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new H2-antagonists--are we prescribing them?
    Gilliland A; Mills K; Steele K
    J R Coll Gen Pract; 1989 Sep; 39(326):387. PubMed ID: 2575170
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery.
    Behrend C; Jeppesen PB; Mortensen PB
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):397-400. PubMed ID: 7614100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.
    Neut C; Bulois P; Desreumaux P; Membré JM; Lederman E; Gambiez L; Cortot A; Quandalle P; van Kruiningen H; Colombel JF
    Am J Gastroenterol; 2002 Apr; 97(4):939-46. PubMed ID: 12003430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.